Displaying 500 actively recruiting clinical trials nationwide

Study Name Sponsor Status Trial Phase Quota Distance
A Clinical Trial for the Surgical Treatment of Elderly Distal Radius Fractures University of Michigan Recruiting
3
Trial Phase
623
Trial Size
2.06 2 miles
RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty Boston Scientific Corporation Recruiting
3
Trial Phase
396
Trial Size
2.06 2 miles
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder Allergan Recruiting
3
Trial Phase
500
Trial Size
4.84 5 miles
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease Gilead Sciences Recruiting
2
Trial Phase
75
Trial Size
4.84 5 miles
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder Allergan Recruiting
3
Trial Phase
600
Trial Size
4.84 5 miles
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03) Allergan Recruiting
3
Trial Phase
700
Trial Size
4.84 5 miles
A research study for adults, 18 to 65 with treatment Resistant Major Depressive Disorder Axsome Therapeutics, Inc. Recruiting
3
Trial Phase
350
Trial Size
5.21 5 miles
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate Pfizer Available
3
Trial Phase
0
Trial Size
7.68 8 miles
Mupirocin-Iodophor ICU Decolonization Swap Out Trial Harvard Pilgrim Health Care Recruiting
4
Trial Phase
137
Trial Size
7.68 8 miles
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) Inova Health Care Services Recruiting
1
Trial Phase
90
Trial Size
10.40 10 miles
Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Alliance for Clinical Trials in Oncology Recruiting
3
Trial Phase
2936
Trial Size
10.40 10 miles
Lyme Test Indication Combinations (LyTIC) Study Oxford Immunotec Recruiting N/A
500
Trial Size
11.84 12 miles
Long-Term Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women AbbVie Recruiting
3
Trial Phase
600
Trial Size
12.41 12 miles
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Southwest Oncology Group Recruiting
3
Trial Phase
1900
Trial Size
12.95 13 miles
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension Allergan Recruiting
3
Trial Phase
600
Trial Size
12.95 13 miles
Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine Allergan Recruiting
3
Trial Phase
1650
Trial Size
12.95 13 miles
Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease Kala Pharmaceuticals, Inc. Recruiting
3
Trial Phase
900
Trial Size
12.95 13 miles
Connect® MM- The Multiple Myeloma Disease Registry Celgene Corporation Recruiting N/A
3000
Trial Size
13.20 13 miles
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease Gilead Sciences Recruiting
3
Trial Phase
1320
Trial Size
13.20 13 miles
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Pfizer Recruiting
2
Trial Phase
360
Trial Size
13.20 13 miles
Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis Gilead Sciences Recruiting
2
Trial Phase
250
Trial Size
13.20 13 miles
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis Janssen Biotech, Inc. Recruiting N/A
6000
Trial Size
13.20 13 miles
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis Gilead Sciences Recruiting
3
Trial Phase
1300
Trial Size
13.20 13 miles
A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis AbbVie Recruiting
2
Trial Phase
1055
Trial Size
13.20 13 miles
The Circulating Cell-free Genome Atlas Study GRAIL, Inc. Recruiting N/A
10000
Trial Size
13.20 13 miles
Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD) Gilead Sciences Recruiting
2
Trial Phase
100
Trial Size
13.20 13 miles
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis Gilead Sciences Recruiting
3
Trial Phase
1000
Trial Size
13.20 13 miles
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease Gilead Sciences Recruiting
3
Trial Phase
1000
Trial Size
13.20 13 miles
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps Hoffmann-La Roche Recruiting
3
Trial Phase
120
Trial Size
13.49 13 miles
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids ObsEva SA Recruiting
3
Trial Phase
500
Trial Size
13.84 14 miles
Strep A FIA Field Study, Sofia Quidel Corporation Recruiting N/A
1200
Trial Size
13.89 14 miles
Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Sanofi Recruiting
3
Trial Phase
360
Trial Size
14.19 14 miles
A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Patients With Asthma Teva Pharmaceutical Industries Recruiting
3
Trial Phase
400
Trial Size
14.19 14 miles
Complementary Management of Chronic Neck and/or Low Back Pain With a Pain Relief Kit Sport and Spine Rehab Clinical Research Foundation Recruiting N/A
30
Trial Size
14.19 14 miles
Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function Protalix Recruiting
3
Trial Phase
78
Trial Size
14.19 14 miles
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment National Cancer Institute (NCI) Recruiting
3
Trial Phase
224
Trial Size
15.58 16 miles
Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer Academic and Community Cancer Research United Recruiting
2
Trial Phase
200
Trial Size
15.58 16 miles
A Phase 1b/2 Study of OMP-59R5 in Combination With Etoposide and Platinum Therapy in Subjects With Untreated Extensive Stage Small Cell Lung Cancer (PINNACLE) OncoMed Pharmaceuticals, Inc. Recruiting
1
Trial Phase
80
Trial Size
15.58 16 miles
Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma ADC Therapeutics SARL Recruiting
1
Trial Phase
90
Trial Size
15.58 16 miles
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
855
Trial Size
15.58 16 miles
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) Bristol-Myers Squibb Recruiting
3
Trial Phase
642
Trial Size
15.58 16 miles
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers Bristol-Myers Squibb Recruiting
3
Trial Phase
1000
Trial Size
15.58 16 miles
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer Mirati Therapeutics Inc. Recruiting
2
Trial Phase
209
Trial Size
15.58 16 miles
Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC Mirati Therapeutics Inc. Recruiting
1
Trial Phase
119
Trial Size
15.58 16 miles
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors CytomX Therapeutics Recruiting
1
Trial Phase
150
Trial Size
15.58 16 miles
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease Janssen Research & Development, LLC Recruiting
2
Trial Phase
450
Trial Size
15.58 16 miles
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) in Patients With Select Advanced or Metastatic Solid Tumors Nektar Therapeutics Recruiting
1
Trial Phase
250
Trial Size
15.58 16 miles
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) G1 Therapeutics, Inc. Recruiting
2
Trial Phase
90
Trial Size
15.58 16 miles
Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI) National Institutes of Health Clinical Center (CC) Recruiting N/A
5000
Trial Size
15.58 16 miles
Oral Calcitriol With Ketoconazole in CRPC Inova Health Care Services Recruiting
2
Trial Phase
15
Trial Size
15.58 16 miles
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Extensive Stage Small Cell Lung Cancer (SCLC) G1 Therapeutics, Inc. Recruiting
2
Trial Phase
100
Trial Size
15.58 16 miles
Tepotinib Phase II in NSCLC Harbouring MET Exon 14 (METex14) Skipping Alterations EMD Serono Recruiting
2
Trial Phase
120
Trial Size
15.58 16 miles
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Hoffmann-La Roche Recruiting
3
Trial Phase
1300
Trial Size
15.58 16 miles
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL Elorac, Inc. Recruiting
3
Trial Phase
160
Trial Size
15.58 16 miles
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer National Cancer Institute (NCI) Recruiting
3
Trial Phase
1000
Trial Size
15.58 16 miles
A Study of ABBV-181 in Participants With Advanced Solid Tumors AbbVie Recruiting
1
Trial Phase
158
Trial Size
15.58 16 miles
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) Merck Sharp & Dohme Corp. Recruiting
1
Trial Phase
180
Trial Size
15.58 16 miles
A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma Bristol-Myers Squibb Recruiting
3
Trial Phase
800
Trial Size
15.58 16 miles
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer Astellas Pharma Inc Recruiting
2
Trial Phase
120
Trial Size
15.58 16 miles
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors AbbVie Recruiting
1
Trial Phase
100
Trial Size
15.58 16 miles
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) Hoffmann-La Roche Recruiting
2
Trial Phase
580
Trial Size
15.58 16 miles
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis Gilead Sciences Recruiting
3
Trial Phase
800
Trial Size
15.58 16 miles
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Gilead Sciences Recruiting
3
Trial Phase
800
Trial Size
15.58 16 miles
ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma Inova Health Care Services Recruiting
2
Trial Phase
20
Trial Size
15.58 16 miles
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer Eli Lilly and Company Recruiting
1
Trial Phase
74
Trial Size
15.58 16 miles
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199) Merck Sharp & Dohme Corp. Recruiting
2
Trial Phase
370
Trial Size
15.58 16 miles
Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use Allergan Recruiting
4
Trial Phase
340
Trial Size
15.58 16 miles
A Study of ABBV-927, an Immunotherapy, in Participants With Advanced Solid Tumors AbbVie Recruiting
1
Trial Phase
180
Trial Size
15.58 16 miles
Utilizing Multiomic Advanced Diagnostics to Identify CDK 4/6 Inhibitor Response Predictors and a Post-treatment Multiomic Signature for Patients With ER+/HER2- Metastatic Breast Cancer Translational Drug Development Recruiting N/A
100
Trial Size
15.58 16 miles
An Open-Label Phase 1/2 Study of INCB039110 in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer Incyte Corporation Recruiting
1
Trial Phase
57
Trial Size
15.58 16 miles
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy Boston Biomedical, Inc Recruiting
2
Trial Phase
200
Trial Size
15.58 16 miles
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission Astellas Pharma Inc Recruiting
3
Trial Phase
354
Trial Size
15.58 16 miles
A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer Bristol-Myers Squibb Recruiting
4
Trial Phase
200
Trial Size
15.58 16 miles
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer Novartis Recruiting
3
Trial Phase
2000
Trial Size
15.58 16 miles
A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, in Subjects With Advanced Solid Tumors Astellas Pharma Inc Recruiting
1
Trial Phase
200
Trial Size
15.58 16 miles
Palbociclib in Real World Practice Pfizer Recruiting N/A
1500
Trial Size
15.58 16 miles
A Study of LAM-003 in Patients With Acute Myeloid Leukemia Lam Therapeutics Inc. Recruiting
1
Trial Phase
48
Trial Size
15.58 16 miles
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease Eli Lilly and Company Recruiting
2
Trial Phase
285
Trial Size
15.58 16 miles
Study of ASTX029 in Subjects With Advanced Solid Tumors Astex Pharmaceuticals Recruiting
1
Trial Phase
300
Trial Size
15.58 16 miles
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
4872
Trial Size
15.73 16 miles
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) Boehringer Ingelheim Recruiting
3
Trial Phase
4126
Trial Size
15.73 16 miles
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Forest Laboratories Recruiting
3
Trial Phase
1100
Trial Size
16.10 16 miles
Non-Invasive Screening for Fetal Aneuploidy Progenity, Inc. Recruiting N/A
340
Trial Size
16.10 16 miles
National Prevalence and Impact of Noninvasive Prenatal Testing Obstetrix Medical Group Recruiting N/A
1000
Trial Size
16.10 16 miles
A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study Apollo Endosurgery, Inc. Recruiting N/A
325
Trial Size
16.10 16 miles
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Baxalta US Inc. Recruiting
2
Trial Phase
90
Trial Size
16.10 16 miles
Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection National Cancer Institute (NCI) Recruiting
1
Trial Phase
26
Trial Size
16.10 16 miles
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC Novartis Available N/A
0
Trial Size
16.10 16 miles
LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris LEO Pharma Recruiting
3
Trial Phase
832
Trial Size
16.10 16 miles
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC Novartis Recruiting
3
Trial Phase
3775
Trial Size
16.10 16 miles
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company Recruiting
3
Trial Phase
195
Trial Size
16.10 16 miles
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer Hoffmann-La Roche Recruiting
3
Trial Phase
850
Trial Size
16.10 16 miles
Vascular Inflammation in Psoriasis - Apremilast University of Pennsylvania Recruiting
4
Trial Phase
70
Trial Size
16.10 16 miles
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure Duke University Recruiting N/A
8000
Trial Size
16.10 16 miles
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen Hoffmann-La Roche Recruiting
3
Trial Phase
730
Trial Size
16.10 16 miles
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) Allergan Recruiting
3
Trial Phase
1050
Trial Size
16.10 16 miles
A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp Celgene Recruiting
3
Trial Phase
300
Trial Size
16.10 16 miles
Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX Altimmune, Inc. Recruiting
2
Trial Phase
60
Trial Size
16.10 16 miles
Efficacy and Safety of Dupilumab in Patients ≥12 to <18 Years of Age, With Moderate-to-Severe Atopic Dermatitis Regeneron Pharmaceuticals Recruiting
3
Trial Phase
240
Trial Size
16.10 16 miles
MAP Study: Methotrexate and Adalimumab in Psoriasis Bakersfield Dermatology & Skin Cancer Medical Group Recruiting
2
Trial Phase
56
Trial Size
16.10 16 miles
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler Teva Pharmaceutical Industries Recruiting
3
Trial Phase
508
Trial Size
16.10 16 miles
Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1) LEO Pharma Recruiting
3
Trial Phase
780
Trial Size
16.10 16 miles
Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Subjects Moderna Therapeutics Recruiting
1
Trial Phase
60
Trial Size
16.10 16 miles
Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults Moderna Therapeutics Recruiting
1
Trial Phase
209
Trial Size
16.10 16 miles
Frozen Blastocyst Transfer Using Conventional Timing Versus Timing by Endometrial Receptivity Analysis Shady Grove Fertility Reproductive Science Center Recruiting N/A
800
Trial Size
16.10 16 miles
5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme Sidney Kimmel Comprehensive Cancer Center Recruiting
1
Trial Phase
46
Trial Size
16.37 16 miles
Expanded Access Treatment Protocol CA204-143 Bristol-Myers Squibb Available N/A
0
Trial Size
16.48 16 miles
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Dana-Farber Cancer Institute Recruiting
2
Trial Phase
500
Trial Size
16.48 16 miles
An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures GlaxoSmithKline Recruiting
4
Trial Phase
100
Trial Size
16.48 16 miles
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
16.48 16 miles
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 Pfizer Available N/A
0
Trial Size
16.48 16 miles
A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin Lymphoma Takeda Recruiting
1
Trial Phase
100
Trial Size
16.48 16 miles
Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures Eisai Inc. Recruiting
4
Trial Phase
300
Trial Size
16.48 16 miles
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer ARMO BioSciences Recruiting
3
Trial Phase
566
Trial Size
16.48 16 miles
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures Sunovion Recruiting
4
Trial Phase
190
Trial Size
16.48 16 miles
Elotuzumab, Lenalidomide and Dexamethasone (ERd) in the Induction, Consolidation and Maintenance Treatment of Transplant-Eligible, Newly Diagnosed Multiple Myeloma Patients SCRI Development Innovations, LLC Recruiting
2
Trial Phase
53
Trial Size
16.48 16 miles
A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma Janssen Scientific Affairs, LLC Recruiting
2
Trial Phase
100
Trial Size
16.48 16 miles
A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma Taiho Oncology, Inc. Recruiting
1
Trial Phase
243
Trial Size
16.48 16 miles
Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy Eisai Inc. Recruiting N/A
2000
Trial Size
16.48 16 miles
Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies Takeda Recruiting
2
Trial Phase
20
Trial Size
16.48 16 miles
A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer Janssen Research & Development, LLC Recruiting
1
Trial Phase
96
Trial Size
16.48 16 miles
Persona Partial Knee Clinical Outcomes Study Zimmer Biomet Recruiting N/A
600
Trial Size
16.48 16 miles
Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102) Incyte Corporation Recruiting
1
Trial Phase
45
Trial Size
16.48 16 miles
A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes Helsinn Healthcare SA Recruiting
2
Trial Phase
120
Trial Size
16.48 16 miles
Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder National Institutes of Health Clinical Center (CC) Recruiting N/A
160
Trial Size
16.48 16 miles
A Phase 2 Study of CX-8998 in Adolescents and Young Adults With Generalized Epileptic Syndromes With Absence Seizures Cavion LLC Recruiting
2
Trial Phase
30
Trial Size
16.48 16 miles
Treatment of Type 2 Diabetes With Ketogenic Diet Mid-Atlantic Epilepsy and Sleep Center, LLC Recruiting N/A
50
Trial Size
16.48 16 miles
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury Avanir Pharmaceuticals Recruiting
2
Trial Phase
150
Trial Size
16.52 17 miles
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005) Merck Sharp & Dohme Corp. Recruiting
2
Trial Phase
215
Trial Size
16.72 17 miles
The HOPE Study: Characterizing Patients With Hepatitis B and C University of Maryland Recruiting N/A
550
Trial Size
16.72 17 miles
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. Recruiting
3
Trial Phase
320
Trial Size
16.72 17 miles
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics Hoffmann-La Roche Recruiting
2
Trial Phase
180
Trial Size
16.72 17 miles
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adults at Imminent Risk for Suicide Janssen Research & Development, LLC Recruiting
3
Trial Phase
224
Trial Size
16.72 17 miles
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo Shire Recruiting
3
Trial Phase
930
Trial Size
17.64 18 miles
Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis Georgetown University Recruiting N/A
600
Trial Size
17.64 18 miles
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo Shire Recruiting
3
Trial Phase
721
Trial Size
17.64 18 miles
Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion Senju USA, Inc. Recruiting
3
Trial Phase
260
Trial Size
17.64 18 miles
The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse Pop Medical Solutions Recruiting N/A
60
Trial Size
17.64 18 miles
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia National Cancer Institute (NCI) Recruiting
3
Trial Phase
4895
Trial Size
17.85 18 miles
The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial Inova Health Care Services Recruiting N/A
30
Trial Size
17.85 18 miles
A Registry for Patients Taking Uptravi Actelion Recruiting N/A
500
Trial Size
17.85 18 miles
A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease Actelion Recruiting
2
Trial Phase
300
Trial Size
17.85 18 miles
The PARTNER 3 - AVIV Trial Edwards Lifesciences Recruiting
3
Trial Phase
125
Trial Size
17.85 18 miles
Comminuted Intra-Articular Distal Tibia Fracture Fixation Using Computer Techniques Inova Health Care Services Recruiting N/A
40
Trial Size
17.85 18 miles
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Boehringer Ingelheim Recruiting
3
Trial Phase
600
Trial Size
17.85 18 miles
Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture Inova Health Care Services Recruiting N/A
100
Trial Size
17.85 18 miles
Multi-epitope Folate Receptor Alpha Peptide Vaccine, Sargramostim, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer Academic and Community Cancer Research United Recruiting
2
Trial Phase
280
Trial Size
17.85 18 miles
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial Indiana University Recruiting
2
Trial Phase
130
Trial Size
17.85 18 miles
Evaluate the Safety and Efficacy of EXPAREL When Administered Via Infiltration Into the TAP vs. Bupivacaine Alone in Subjects Undergoing Elective C-Sections Pacira Pharmaceuticals, Inc Recruiting
4
Trial Phase
152
Trial Size
17.85 18 miles
Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage Edge Therapeutics Inc Recruiting
3
Trial Phase
374
Trial Size
17.85 18 miles
Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease Inova Health Care Services Recruiting N/A
60
Trial Size
17.85 18 miles
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib Novartis Recruiting
3
Trial Phase
140
Trial Size
18.05 18 miles
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors Center for International Blood and Marrow Transplant Research Recruiting
3
Trial Phase
35000
Trial Size
18.51 19 miles
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine Sanofi Recruiting
3
Trial Phase
505
Trial Size
18.51 19 miles
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Reata Pharmaceuticals, Inc. Recruiting
2
Trial Phase
210
Trial Size
18.51 19 miles
Using Values Affirmation to Reduce the Effects of Perceived Discrimination on Hypertension Disparities University of Colorado, Denver Recruiting N/A
1330
Trial Size
18.51 19 miles
Effect of at Home Pain Management Products on Acute Low Back Pain, Disability, and Range of Motion Sport and Spine Rehab Clinical Research Foundation Recruiting N/A
120
Trial Size
18.51 19 miles
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus Sanofi Recruiting
2
Trial Phase
270
Trial Size
18.51 19 miles
Efficacy and Safety of Sotagliflozin Versus Placebo in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents Sanofi Recruiting
3
Trial Phase
560
Trial Size
18.51 19 miles
Progressing Ankle Brace Restriction on Walking and Running Gait Characteristics in Healthy Individuals Sport and Spine Rehab Clinical Research Foundation Recruiting N/A
20
Trial Size
18.51 19 miles
Clostridium Difficile Vaccine Efficacy Trial Pfizer Recruiting
3
Trial Phase
15776
Trial Size
18.53 19 miles
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Infectious Diseases Physicians, Inc. Recruiting
4
Trial Phase
50
Trial Size
18.53 19 miles
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. Pfizer Recruiting
3
Trial Phase
1590
Trial Size
18.61 19 miles
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin Sanofi Recruiting
3
Trial Phase
500
Trial Size
18.61 19 miles
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function Kowa Research Institute, Inc. Recruiting
3
Trial Phase
630
Trial Size
18.69 19 miles
A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment Ironwood Pharmaceuticals, Inc. Recruiting
4
Trial Phase
600
Trial Size
18.69 19 miles
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Eli Lilly and Company Recruiting
3
Trial Phase
1800
Trial Size
18.69 19 miles
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies Novartis Recruiting N/A
3600
Trial Size
19.15 19 miles
Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis U.S. Army Medical Research and Materiel Command Available N/A
0
Trial Size
19.15 19 miles
Radiation and Androgen Ablation for Prostate Cancer Sidney Kimmel Comprehensive Cancer Center Recruiting
1
Trial Phase
105
Trial Size
19.15 19 miles
Artisan Aphakia Lens for the Correction of Aphakia in Children Ophtec USA Recruiting
3
Trial Phase
300
Trial Size
19.15 19 miles
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Oregon Health and Science University Recruiting
2
Trial Phase
102
Trial Size
19.15 19 miles
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation National Institutes of Health Clinical Center (CC) Recruiting N/A
334
Trial Size
19.15 19 miles
Evaluation of Military Service and Family Members for Post Concussive and Posttraumatic Stress Symptoms Uniformed Services University of the Health Sciences Recruiting N/A
2000
Trial Size
19.15 19 miles
SJM MRI Diagnostic Imaging Registry (IDE) St. Jude Medical Recruiting N/A
150
Trial Size
19.15 19 miles
Observational Study of Males With Creatine Transporter Deficiency Lumos Pharma Recruiting N/A
50
Trial Size
19.15 19 miles
Evaluation of the Safety and Efficacy of Angiotensin 1-7 (Ang-(1-7)) to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery. University of Arizona Recruiting
2
Trial Phase
104
Trial Size
19.15 19 miles
Fecal Microbiota Transplant National Registry American Gastroenterological Association Recruiting N/A
4000
Trial Size
19.15 19 miles
Blood-Brain Barrier Disruption in Stroke People With White Matter Hyperintensities National Institutes of Health Clinical Center (CC) Recruiting N/A
310
Trial Size
19.15 19 miles
Salivary Evaluation in Normal Volunteers National Institutes of Health Clinical Center (CC) Recruiting N/A
250
Trial Size
19.48 19 miles
Cancer in Inherited Bone Marrow Failure Syndromes National Institutes of Health Clinical Center (CC) Recruiting N/A
4000
Trial Size
19.48 19 miles
Normal Blood, Bone Marrow and Buccal Mucosa Protocol National Institutes of Health Clinical Center (CC) Recruiting N/A
500
Trial Size
19.48 19 miles
Effect of Filarial Infection on Immune Responses in Latent Tuberculosis National Institutes of Health Clinical Center (CC) Recruiting N/A
4000
Trial Size
19.48 19 miles
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures National Institutes of Health Clinical Center (CC) Recruiting N/A
3215
Trial Size
19.48 19 miles
Collection of Peripheral Blood and Bone Marrow From Healthy Donors for Use in In Vitro Research National Institutes of Health Clinical Center (CC) Recruiting N/A
150
Trial Size
19.48 19 miles
Neurobiology of Psychogenic Movement Disorder and Non-Epileptic Seizures National Institutes of Health Clinical Center (CC) Recruiting N/A
305
Trial Size
19.48 19 miles
Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults National Institutes of Health Clinical Center (CC) Recruiting N/A
375
Trial Size
19.48 19 miles
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes National Institutes of Health Clinical Center (CC) Recruiting N/A
99999999
Trial Size
19.48 19 miles
EPI-743 for Metabolism or Mitochondrial Disorders National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
20
Trial Size
19.48 19 miles
Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples National Institutes of Health Clinical Center (CC) Recruiting N/A
100
Trial Size
19.48 19 miles
Determination of Kidney Function National Institutes of Health Clinical Center (CC) Recruiting N/A
9999999
Trial Size
19.48 19 miles
Environmental Risk Factors for Myositis in Military Personnel National Institutes of Health Clinical Center (CC) Recruiting N/A
300
Trial Size
19.48 19 miles
Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes Eli Lilly and Company Available N/A
0
Trial Size
19.48 19 miles
Study of Chediak-Higashi Syndrome National Institutes of Health Clinical Center (CC) Recruiting N/A
60
Trial Size
19.48 19 miles
Studies of Blood and Reproductive Fluids in HIV-Infected and Non-HIV-Infected Persons National Institutes of Health Clinical Center (CC) Recruiting N/A
2000
Trial Size
19.48 19 miles
Genetic Studies of Insulin and Diabetes National Institutes of Health Clinical Center (CC) Recruiting N/A
99999999
Trial Size
19.48 19 miles
Study of Heart Transplant Rejection National Institutes of Health Clinical Center (CC) Recruiting N/A
482
Trial Size
19.48 19 miles
New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis Pneumonia National Institutes of Health Clinical Center (CC) Recruiting N/A
1500
Trial Size
19.48 19 miles
Tests of Functional Magnetic Resonance Imaging Techniques National Institutes of Health Clinical Center (CC) Recruiting N/A
100
Trial Size
19.48 19 miles
The Role of Hormones in Postpartum Mood Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
80
Trial Size
19.48 19 miles
Diabetes and Heart Disease Risk in Blacks National Institutes of Health Clinical Center (CC) Recruiting N/A
1132
Trial Size
19.48 19 miles
A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression National Institutes of Health Clinical Center (CC) Recruiting N/A
50
Trial Size
19.48 19 miles
Donor Stem Cell Transplantation for Congenital Immunodeficiencies National Institutes of Health Clinical Center (CC) Recruiting
0
Trial Phase
100
Trial Size
19.48 19 miles
Psychological Benefits of a Normalized Camping Experience for Children With Cancer National Institutes of Health Clinical Center (CC) Recruiting N/A
9999
Trial Size
19.48 19 miles
Studies of Frontal Lobe Brain Functioning in Schizophrenia National Institutes of Health Clinical Center (CC) Recruiting N/A
1070
Trial Size
19.48 19 miles
Brain Stimulation and Vision Testing National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
320
Trial Size
19.48 19 miles
Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints Kirby Institute Recruiting
1
Trial Phase
60
Trial Size
19.48 19 miles
A Study of Subcutaneous Recombinant Human hetIL-15 (IL15/sIL-15Ra) in Adults With Metastatic Cancers Admune Therapeutics LLC Recruiting
1
Trial Phase
42
Trial Size
19.48 19 miles
Pathogenesis of Glomerulosclerosis National Institutes of Health Clinical Center (CC) Recruiting N/A
99999999
Trial Size
19.48 19 miles
Study of Inherited Neurological Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
2500
Trial Size
19.48 19 miles
Study of Arthritis and Related Conditions National Institutes of Health Clinical Center (CC) Recruiting N/A
99999999
Trial Size
19.48 19 miles
Antibody Production in Immune Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
50
Trial Size
19.48 19 miles
Autologous Transplant of EFS-ADA Modified Bone Marrow Cells for ADA-Deficient Severe Combined Immunodeficiency (SCID) University of California, Los Angeles Recruiting
1
Trial Phase
20
Trial Size
19.48 19 miles
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
3
Trial Phase
320
Trial Size
19.48 19 miles
Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
95
Trial Size
19.48 19 miles
YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
30
Trial Size
19.48 19 miles
Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
15
Trial Size
19.48 19 miles
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Children's Oncology Group Recruiting
1
Trial Phase
51
Trial Size
19.48 19 miles
Diagnosis and Management of Inflammatory and Infectious Diseases National Institutes of Health Clinical Center (CC) Recruiting N/A
250
Trial Size
19.48 19 miles
Effects of Transcranial Magnetic Stimulation on Object Recognition National Institutes of Health Clinical Center (CC) Recruiting N/A
15
Trial Size
19.48 19 miles
Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
25
Trial Size
19.48 19 miles
Fat Cell Size in Insulin Resistance National Institutes of Health Clinical Center (CC) Recruiting N/A
0
Trial Size
19.48 19 miles
AZD6244 in Children With Low-Grade Gliomas National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
18
Trial Size
19.48 19 miles
Studies on Tumors of the Thyroid National Institutes of Health Clinical Center (CC) Recruiting N/A
99999
Trial Size
19.48 19 miles
Study of New Magnetic Resonance Imaging Methods of the Brain National Institutes of Health Clinical Center (CC) Recruiting N/A
650
Trial Size
19.48 19 miles
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
280
Trial Size
19.48 19 miles
Evaluation and Intervention for the Effects of Osteogenesis Imperfecta National Institutes of Health Clinical Center (CC) Recruiting N/A
100
Trial Size
19.48 19 miles
Deep Brain Stimulation Surgery for Movement Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
100
Trial Size
19.48 19 miles
Effects of Modafinil on Brain Function in Patients With Schizophrenia National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
210
Trial Size
19.48 19 miles
Study and Treatment of Inflammatory Muscle Diseases National Institutes of Health Clinical Center (CC) Recruiting N/A
99999999
Trial Size
19.48 19 miles
Genetic Studies of Non-Alcoholic Fatty Liver Disease National Institutes of Health Clinical Center (CC) Recruiting N/A
1000
Trial Size
19.48 19 miles
Raltegravir for HAM/TSP National Institutes of Health Clinical Center (CC) Recruiting
0
Trial Phase
22
Trial Size
19.48 19 miles
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
50
Trial Size
19.48 19 miles
Genetics of Inherited Eye Disease National Institutes of Health Clinical Center (CC) Recruiting N/A
1000
Trial Size
19.48 19 miles
Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases) National Institutes of Health Clinical Center (CC) Recruiting N/A
2200
Trial Size
19.48 19 miles
Interhemispheric Interaction of Parieto-Motor Cortico-Cortical Plasticity National Institutes of Health Clinical Center (CC) Recruiting N/A
15
Trial Size
19.48 19 miles
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
90
Trial Size
19.48 19 miles
Clinical and Physiological Studies of Tremor Syndromes National Institutes of Health Clinical Center (CC) Recruiting N/A
450
Trial Size
19.48 19 miles
Collection of Tissue Blocks or Slides From Patients With Cancer National Institutes of Health Clinical Center (CC) Recruiting N/A
500
Trial Size
19.48 19 miles
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
46
Trial Size
19.48 19 miles
Long Term Retention of Protspectively Obtained Biospecimens National Institutes of Health Clinical Center (CC) Recruiting N/A
1000
Trial Size
19.48 19 miles
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
108
Trial Size
19.48 19 miles
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations National Institutes of Health Clinical Center (CC) Recruiting N/A
339
Trial Size
19.48 19 miles
Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
80
Trial Size
19.48 19 miles
Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
55
Trial Size
19.48 19 miles
PEN-866 in Patients With Advanced Solid Malignancies Tarveda Therapeutics Recruiting
1
Trial Phase
150
Trial Size
19.48 19 miles
Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans Azevan Pharmaceuticals Recruiting
1
Trial Phase
47
Trial Size
19.48 19 miles
T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
76
Trial Size
19.48 19 miles
Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
70
Trial Size
19.48 19 miles
Dopamine and Motor Learning in Cerebral Palsy National Institutes of Health Clinical Center (CC) Recruiting N/A
120
Trial Size
19.48 19 miles
The Immune Checkpoint Inhibitor Pembrolizumab in Combination With Oral Decitabine and Tetrahydrouridine as First-Line Therapy for Inoperable, Locally Advanced or Metastatic Non-small Cell Lung Cancer National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
44
Trial Size
19.48 19 miles
Effects of External Ear Stimulation on Pain Perception and Mood National Institutes of Health Clinical Center (CC) Recruiting N/A
76
Trial Size
19.48 19 miles
Effect of Transcranial Magnetic Stimulation to the Dorsolateral Prefrontal Cortex on Anxiety Potentiated Startle National Institutes of Health Clinical Center (CC) Recruiting N/A
184
Trial Size
19.48 19 miles
CADASIL Disease Discovery National Institutes of Health Clinical Center (CC) Recruiting N/A
20
Trial Size
19.48 19 miles
Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
26
Trial Size
19.48 19 miles
Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes National Institutes of Health Clinical Center (CC) Recruiting
4
Trial Phase
50
Trial Size
19.48 19 miles
Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Rhythm Pharmaceuticals, Inc. Recruiting
2
Trial Phase
25
Trial Size
19.48 19 miles
Safety and Tolerability of Vorinostat for the Treatment of Moderate-to-Severe Crohn s Disease National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
30
Trial Size
19.48 19 miles
Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM Aduro Biotech, Inc. Recruiting
2
Trial Phase
35
Trial Size
19.48 19 miles
Clonal Evolution in Follicular Lymphoma National Institutes of Health Clinical Center (CC) Recruiting N/A
88
Trial Size
19.48 19 miles
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors National Institutes of Health Clinical Center (CC) Recruiting N/A
250
Trial Size
19.48 19 miles
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
118
Trial Size
19.48 19 miles
Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
32
Trial Size
19.48 19 miles
Sensory and Opioid Mechanisms of Affective Touch National Institutes of Health Clinical Center (CC) Recruiting N/A
30
Trial Size
19.48 19 miles
Discovery of Sirolimus Sensitive Biomarkers in Blood National Institutes of Health Clinical Center (CC) Recruiting N/A
24
Trial Size
19.48 19 miles
Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? National Institutes of Health Clinical Center (CC) Recruiting N/A
35
Trial Size
19.48 19 miles
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease National Institutes of Health Clinical Center (CC) Recruiting N/A
230
Trial Size
19.48 19 miles
Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration National Institutes of Health Clinical Center (CC) Recruiting N/A
25
Trial Size
19.48 19 miles
Understanding How Cigarette Direct Mail Marketing Influences Smoking Behaviors Among High and Low Socioeconomic Status Young Adult Smokers National Institutes of Health Clinical Center (CC) Recruiting N/A
530
Trial Size
19.48 19 miles
Disease Natural History and Biomarkers of SPG3A, SPG4A, and SPG31 National Institutes of Health Clinical Center (CC) Recruiting N/A
300
Trial Size
19.48 19 miles
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
52
Trial Size
19.48 19 miles
Natural History, Pathogenesis, and Outcome of Ocular Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
1000
Trial Size
19.48 19 miles
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
35
Trial Size
19.48 19 miles
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
100
Trial Size
19.48 19 miles
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia National Institutes of Health Clinical Center (CC) Recruiting N/A
200
Trial Size
19.48 19 miles
T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
125
Trial Size
19.48 19 miles
Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor National Institutes of Health Clinical Center (CC) Recruiting N/A
78
Trial Size
19.48 19 miles
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
24
Trial Size
19.48 19 miles
Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health National Institutes of Health Clinical Center (CC) Recruiting N/A
206
Trial Size
19.48 19 miles
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
90
Trial Size
19.48 19 miles
Technical Development of Clinical Laboratory Studies National Institutes of Health Clinical Center (CC) Recruiting N/A
126
Trial Size
19.48 19 miles
Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
250
Trial Size
19.48 19 miles
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer National Cancer Institute (NCI) Recruiting
3
Trial Phase
739
Trial Size
19.48 19 miles
CD8 Reactivity to Microorganisms in Blood and Breast Milk National Institutes of Health Clinical Center (CC) Recruiting N/A
80
Trial Size
19.48 19 miles
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
330
Trial Size
19.48 19 miles
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST) National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
20
Trial Size
19.48 19 miles
Avelumab for People With Recurrent Respiratory Papillomatosis National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
40
Trial Size
19.48 19 miles
Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Trial to Determine Safety and Development of Protective Efficacy After Exposure to Only Pre-erythrocytic Stages of Plasmodium Falciparum National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
230
Trial Size
19.48 19 miles
Photic Blink Reflex in People With Blepharospasm and Increased Blinking National Institutes of Health Clinical Center (CC) Recruiting N/A
72
Trial Size
19.48 19 miles
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
250
Trial Size
19.48 19 miles
Impact of a Short-Term Analytical Treatment Interruption and Re-Initiation of Antiretroviral Therapy on Immunologic and Virologic Parameters in HIV-Infected Individuals National Institutes of Health Clinical Center (CC) Recruiting N/A
40
Trial Size
19.48 19 miles
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) EMD Serono Recruiting
1
Trial Phase
170
Trial Size
19.48 19 miles
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
100
Trial Size
19.48 19 miles
A Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors Celgene Recruiting
2
Trial Phase
36
Trial Size
19.48 19 miles
Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
84
Trial Size
19.48 19 miles
TG02 Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of TG02 Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
152
Trial Size
19.48 19 miles
Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in People With Functional Movement Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
8
Trial Size
19.48 19 miles
Outcomes and Risk in People With Ependymoma National Institutes of Health Clinical Center (CC) Recruiting N/A
220
Trial Size
19.48 19 miles
Ustekinumab (STELARA ) for the Treatment of Active Sight-Threatening Uveitis National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
7
Trial Size
19.48 19 miles
Right Heart Catheterization Using Magnetic Resonance Imaging Fluoroscopy and Passive Guidewires National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
12
Trial Size
19.48 19 miles
PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
17
Trial Size
19.48 19 miles
Pathophysiology of Acute Pain in Patients With Sickle Cell Disease National Institutes of Health Clinical Center (CC) Recruiting N/A
100
Trial Size
19.48 19 miles
ABMT Augmentation of CBT National Institutes of Health Clinical Center (CC) Recruiting N/A
120
Trial Size
19.48 19 miles
Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
100
Trial Size
19.48 19 miles
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma National Cancer Institute (NCI) Recruiting
2
Trial Phase
24
Trial Size
19.48 19 miles
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
15
Trial Size
19.48 19 miles
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation National Institutes of Health Clinical Center (CC) Recruiting N/A
2000
Trial Size
19.48 19 miles
Neurophysiology of Surround Inhibition in the Human Motor Cortex National Institutes of Health Clinical Center (CC) Recruiting N/A
65
Trial Size
19.48 19 miles
Study to Evaluate the Effect of Nicotinamide Riboside on Immunity National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
58
Trial Size
19.48 19 miles
Effects of Prism Adaption and rTMS on Brain Connectivity and Visual Representation National Institutes of Health Clinical Center (CC) Recruiting N/A
194
Trial Size
19.48 19 miles
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
36
Trial Size
19.48 19 miles
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
3
Trial Size
19.48 19 miles
Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI Novartis Recruiting
2
Trial Phase
36
Trial Size
19.48 19 miles
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors National Institutes of Health Clinical Center (CC) Recruiting N/A
500
Trial Size
19.48 19 miles
Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin Sensitivity National Institutes of Health Clinical Center (CC) Recruiting N/A
200
Trial Size
19.48 19 miles
Novel Positron Emission Tomography (PET) Radiotracer to Image Phosphodiesterase-4B (PDE4B) National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
30
Trial Size
19.48 19 miles
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer National Institutes of Health Clinical Center (CC) Recruiting N/A
240
Trial Size
19.48 19 miles
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*1101 Patients National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
110
Trial Size
19.48 19 miles
Brain Dopaminergic Signaling in Opioid Use Disorders National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
180
Trial Size
19.48 19 miles
Effects of SRX246, a Vasopressin Receptor (V1a) Antagonist, on an Experimental Model of Fear and Anxiety in Humans National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
47
Trial Size
19.48 19 miles
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Washington University School of Medicine Recruiting N/A
1000
Trial Size
19.48 19 miles
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System National Institutes of Health Clinical Center (CC) Recruiting N/A
10000
Trial Size
19.48 19 miles
Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
40
Trial Size
19.48 19 miles
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
62
Trial Size
19.48 19 miles
Immune Checkpoint Inhibitor Nivolumab in People With Select Rare CNS Cancers National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
180
Trial Size
19.48 19 miles
Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta 3-Adrenergic Receptor Agonists National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
75
Trial Size
19.48 19 miles
Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
100
Trial Size
19.48 19 miles
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors Bayer Recruiting
1
Trial Phase
348
Trial Size
19.48 19 miles
Peripheral Blood Stem Cell Collection for Sickle Cell Disease (SCD) Patients National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
15
Trial Size
19.48 19 miles
Leukapheresis for CAR-Therapy Manufacturing National Institutes of Health Clinical Center (CC) Recruiting N/A
120
Trial Size
19.48 19 miles
Functional Connectivity as a Biomarker of rTMS National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
120
Trial Size
19.48 19 miles
Study in Healthy Volunteers to Evaluate the Safety and Immunogenicity of AGS-v, a Universal Mosquito-Borne Disease Vaccine National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
60
Trial Size
19.48 19 miles
NIAID Centralized Sequencing Protocol National Institutes of Health Clinical Center (CC) Recruiting N/A
10000
Trial Size
19.48 19 miles
Loss of Depotentiation in Focal Dystonia National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
40
Trial Size
19.48 19 miles
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
19
Trial Size
19.48 19 miles
A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
70
Trial Size
19.48 19 miles
Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
200
Trial Size
19.48 19 miles
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extra-Nodal Diffuse Large B-cell Lymphomas National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
52
Trial Size
19.48 19 miles
Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD) National Institutes of Health Clinical Center (CC) Recruiting N/A
200
Trial Size
19.48 19 miles
Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy National Institutes of Health Clinical Center (CC) Recruiting N/A
500
Trial Size
19.48 19 miles
Mobile Attention Retraining in Overweight Female Adolescents National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
120
Trial Size
19.48 19 miles
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
32
Trial Size
19.48 19 miles
Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ Yale University Recruiting N/A
20000
Trial Size
19.48 19 miles
CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
50
Trial Size
19.48 19 miles
Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
24
Trial Size
19.48 19 miles
Herpesviruses Reactivation In Hiv-Infected Women Initiating ART (HERA) National Institutes of Health Clinical Center (CC) Recruiting N/A
80
Trial Size
19.48 19 miles
Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
40
Trial Size
19.48 19 miles
Pathophysiology of Dystonia and Complex Regional Pain Syndrome National Institutes of Health Clinical Center (CC) Recruiting N/A
60
Trial Size
19.48 19 miles
Measuring the Latency Connectome in the Central Nervous Systems Using Neuroimaging and Neurophysiological Techniques National Institutes of Health Clinical Center (CC) Recruiting N/A
40
Trial Size
19.48 19 miles
Break It Up: A Study Evaluating Breaking Up Daily Sedentary Behavior in Youth National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
150
Trial Size
19.48 19 miles
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
120
Trial Size
19.48 19 miles
Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
100
Trial Size
19.48 19 miles
Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study National Institutes of Health Clinical Center (CC) Recruiting N/A
69
Trial Size
19.48 19 miles
Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
30
Trial Size
19.48 19 miles
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
90
Trial Size
19.48 19 miles
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors MacroGenics Recruiting
1
Trial Phase
112
Trial Size
19.48 19 miles
Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL Therapeutic Advances in Childhood Leukemia Consortium Recruiting
1
Trial Phase
30
Trial Size
19.48 19 miles
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
29
Trial Size
19.48 19 miles
Long-Term Stability of Oral Microbiome Samples National Institutes of Health Clinical Center (CC) Recruiting N/A
30
Trial Size
19.48 19 miles
Randomized Controlled Trial of OnabotulinumtoxinA for Depression in Parkinson Disease Johns Hopkins University Recruiting
1
Trial Phase
60
Trial Size
19.48 19 miles
Influence of Brain Oscillation-Dependent TMS on Motor Function National Institutes of Health Clinical Center (CC) Recruiting N/A
74
Trial Size
19.48 19 miles
Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research National Institutes of Health Clinical Center (CC) Recruiting N/A
1000
Trial Size
19.48 19 miles
Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies National Institutes of Health Clinical Center (CC) Recruiting N/A
2000
Trial Size
19.48 19 miles
Ketogenic Diet (KD) in Alcoholism National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
100
Trial Size
19.48 19 miles
Investigations of Juvenile Neuronal Ceroid Lipofuscinosis National Institutes of Health Clinical Center (CC) Recruiting N/A
50
Trial Size
19.48 19 miles
Durvalumab and Vicinium in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
40
Trial Size
19.48 19 miles
Epigenetic Reprogramming in Relapse/Refractory AML Therapeutic Advances in Childhood Leukemia Consortium Recruiting
1
Trial Phase
24
Trial Size
19.48 19 miles
A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 Neurotech Pharmaceuticals Recruiting
3
Trial Phase
112
Trial Size
19.48 19 miles
A Study to Determine the Safety and Efficacy of Renexus® in Macular Telangiectasia Type 2 Neurotech Pharmaceuticals Recruiting
3
Trial Phase
112
Trial Size
19.48 19 miles
Sample Collection and Tracking for the Developmental Therapeutics Clinic National Institutes of Health Clinical Center (CC) Recruiting N/A
3000
Trial Size
19.48 19 miles
Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1) National Institutes of Health Clinical Center (CC) Recruiting N/A
31
Trial Size
19.48 19 miles
Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
40
Trial Size
19.48 19 miles
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
46
Trial Size
19.48 19 miles
Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
20
Trial Size
19.48 19 miles
The Mechanistic Biology of Primary Immunodeficiency Disorders National Institutes of Health Clinical Center (CC) Recruiting N/A
1100
Trial Size
19.48 19 miles
Point-of-Use Pathogen Identification Tool for Diarrhea National Institutes of Health Clinical Center (CC) Recruiting N/A
1000
Trial Size
19.48 19 miles
Perception, Sensation, Cognition and Action in Humans National Institutes of Health Clinical Center (CC) Recruiting N/A
10200
Trial Size
19.48 19 miles
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study) National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
150
Trial Size
19.48 19 miles
Effect of Ultra Processed Versus Unprocessed Diets on Energy Intake National Institutes of Health Clinical Center (CC) Recruiting N/A
200
Trial Size
19.48 19 miles
Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers With and Without Cerebral Palsy National Institutes of Health Clinical Center (CC) Recruiting N/A
150
Trial Size
19.48 19 miles
Modulation of the Parieto-frontal Communication National Institutes of Health Clinical Center (CC) Recruiting N/A
26
Trial Size
19.48 19 miles
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
40
Trial Size
19.48 19 miles
Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
10
Trial Size
19.48 19 miles
Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
10
Trial Size
19.48 19 miles
Investigating Epilepsy: Screening, Evaluation and Treatment National Institutes of Health Clinical Center (CC) Recruiting N/A
500
Trial Size
19.48 19 miles
Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
30
Trial Size
19.48 19 miles
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA) National Institutes of Health Clinical Center (CC) Recruiting
1
Trial Phase
30
Trial Size
19.48 19 miles
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions National Institutes of Health Clinical Center (CC) Recruiting N/A
1000
Trial Size
19.48 19 miles
Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon National Institutes of Health Clinical Center (CC) Recruiting
2
Trial Phase
32
Trial Size
19.48 19 miles
Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies National Institutes of Health Clinical Center (CC) Recruiting N/A
3000
Trial Size
19.48 19 miles
Evaluation of a Novel PET Radioligand to Image OGA National Institutes of Health Clinical Center (CC) Recruiting N/A
31
Trial Size
19.48 19 miles
Study to Identify the Genetic Variations Associated With Phantom Limb Pain Henry M. Jackson Foundation for the Advancement of Military Medicine Recruiting N/A
1000
Trial Size
19.50 19 miles
Registry of Avance Nerve Graft Evaluating Utilization and Outcomes for the Reconstruction of Peripheral Nerve Discontinuities AxoGen, Inc Recruiting N/A
500
Trial Size
19.50 19 miles
Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria U.S. Army Medical Research and Materiel Command Available N/A
0
Trial Size
19.50 19 miles
Treating Phantom Limb Pain Using Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study University of California, San Diego Recruiting
4
Trial Phase
180
Trial Size
19.50 19 miles
Prospective Evaluation of the ReCell® Autologous Cell Harvesting Device For Specific Compassionate Use Cases Avita Medical Recruiting N/A
48
Trial Size
19.50 19 miles
Biopsychosocial Impact on Caregivers in Patients Undergoing Joint and Spine Surgery Defense and Veterans Center for Integrative Pain Management Recruiting N/A
150
Trial Size
19.50 19 miles
Assessing the Feasibility of a Novel Non-Invasive Sensor for Guiding Wounded Warrior Rehabilitation Henry M. Jackson Foundation for the Advancement of Military Medicine Recruiting N/A
20
Trial Size
19.50 19 miles
Nutrition for Post-Traumatic Headache Uniformed Services University of the Health Sciences Recruiting
2
Trial Phase
300
Trial Size
19.50 19 miles
Characterization of Bio-psychosocial Pain Profiles in the Perioperative Period Defense and Veterans Center for Integrative Pain Management Recruiting N/A
1500
Trial Size
19.50 19 miles
Oculomotor Assessment of Traumatic Brain Injury (TBI) Walter Reed National Military Medical Center Recruiting N/A
240
Trial Size
19.50 19 miles
Evaluation of a Novel Integrative and Intensive Virtual Rehabilitation Program for Service Members Post TBI Henry M. Jackson Foundation for the Advancement of Military Medicine Recruiting N/A
20
Trial Size
19.50 19 miles
Improved Training Program for Fall Prevention of War Fighters Mayo Clinic Recruiting N/A
60
Trial Size
19.50 19 miles
Influence of Vorapaxar on Thrombin Generation and Coagulability Inova Health Care Services Recruiting
4
Trial Phase
100
Trial Size
19.55 20 miles
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug AbbVie Recruiting
3
Trial Phase
1640
Trial Size
19.66 20 miles
2 Weekly Intra-articular Hyaluronan Knee Injections, Given 1 wk. Apart, of HYMOVIS Combined With Physical Exercise Program (PEP) Compared to PEP Alone, in Relatively Young, Active Population of Subjects With Patellofemoral Osteoarthritis (PFOA) and/or Tibiofemoral Osteoarthritis (TFOA) Fidia Pharma USA Inc. Recruiting N/A
146
Trial Size
19.66 20 miles
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug AbbVie Recruiting
3
Trial Phase
630
Trial Size
19.66 20 miles
: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) AbbVie Recruiting
4
Trial Phase
6000
Trial Size
19.67 20 miles
Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection Seres Health Inc Available
2
Trial Phase
29
Trial Size
20.65 21 miles
Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) Neurotech Pharmaceuticals Recruiting
1
Trial Phase
170
Trial Size
20.65 21 miles
BÃœHLMANN fCALâ„¢ ELISA - Aid in Differentiation of IBD From IBS B├╝hlmann Laboratories AG Recruiting N/A
390
Trial Size
20.65 21 miles
Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease RedHill Biopharma Limited Recruiting
3
Trial Phase
100
Trial Size
20.65 21 miles
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps Hoffmann-La Roche Recruiting
3
Trial Phase
120
Trial Size
20.65 21 miles
Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy Prometheus Laboratories Recruiting
2
Trial Phase
240
Trial Size
20.65 21 miles
Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. Pfizer Recruiting
2
Trial Phase
68
Trial Size
20.65 21 miles
A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy Jazz Pharmaceuticals Recruiting
3
Trial Phase
130
Trial Size
20.65 21 miles
Pain Control in Hip Arthroscopy: Comparing Lumbar Plexus Versus Peri-capsular Injection Washington Orthopaedics and Sports Medicine Recruiting N/A
100
Trial Size
20.65 21 miles
Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery Novartis Recruiting
2
Trial Phase
30
Trial Size
20.65 21 miles
Study of PlasmaCap IG in Adults and Children With PIDD Therapure Biopharma Inc Recruiting
3
Trial Phase
74
Trial Size
20.65 21 miles
A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness Jazz Pharmaceuticals Recruiting
2
Trial Phase
49
Trial Size
20.65 21 miles
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff Crestovo LLC Recruiting
2
Trial Phase
240
Trial Size
20.65 21 miles
The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea NightBalance Recruiting N/A
120
Trial Size
20.65 21 miles
A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy Braintree Laboratories Recruiting
3
Trial Phase
450
Trial Size
20.65 21 miles
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy AbbVie Recruiting
3
Trial Phase
855
Trial Size
20.65 21 miles
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy AbbVie Recruiting
3
Trial Phase
300
Trial Size
20.65 21 miles
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) Genentech, Inc. Recruiting
2
Trial Phase
270
Trial Size
20.65 21 miles
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases Sidney Kimmel Comprehensive Cancer Center Recruiting N/A
24
Trial Size
20.71 21 miles
Study of Stereotactic Radiotherapy for Breast Cancer Sidney Kimmel Comprehensive Cancer Center Recruiting
2
Trial Phase
40
Trial Size
20.71 21 miles
Diet, Insulin Sensitivity, and Postprandial Metabolism Physicians Committee for Responsible Medicine Recruiting N/A
60
Trial Size
20.71 21 miles
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors Medical University of South Carolina Recruiting N/A
184
Trial Size
20.71 21 miles
A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopic Patients With Treatments to Optimize the Ocular Surface Before Implantation Whitten Laser Eye Recruiting
4
Trial Phase
40
Trial Size
20.71 21 miles
Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation Johns Hopkins University Recruiting N/A
45
Trial Size
20.71 21 miles
A Study to Evaluate the Raindrop Near Vision Inlay Under Flap or Within Pocket Whitten Laser Eye Recruiting
4
Trial Phase
60
Trial Size
20.71 21 miles
A Nutrition Intervention for Arthritis -4 (WCCR-ARTH4) Physicians Committee for Responsible Medicine Recruiting N/A
40
Trial Size
20.71 21 miles
Development of the ERA-Microbiome Non-invasive Diagnosis Tool Igenomix Recruiting N/A
210
Trial Size
21.12 21 miles
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Taiho Oncology, Inc. Available N/A
0
Trial Size
21.99 22 miles
Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia Merit Medical Systems, Inc. Recruiting
3
Trial Phase
186
Trial Size
21.99 22 miles
Detection and Treatment of Sarcopenia and Myosteatosis in Older African Americans Washington D.C. Veterans Affairs Medical Center Recruiting N/A
140
Trial Size
21.99 22 miles
Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage Georgetown University Available N/A
0
Trial Size
21.99 22 miles
VX15/2503 Treatment for Huntington's Disease Vaccinex Inc. Recruiting
2
Trial Phase
84
Trial Size
21.99 22 miles
A Study of LY2801653 in Advanced Cancer Eli Lilly and Company Recruiting
1
Trial Phase
190
Trial Size
21.99 22 miles
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint Agendia Recruiting N/A
1200
Trial Size
21.99 22 miles
Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors Five Prime Therapeutics, Inc. Recruiting
1
Trial Phase
120
Trial Size
21.99 22 miles
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer Vanderbilt-Ingram Cancer Center Recruiting
1
Trial Phase
74
Trial Size
21.99 22 miles
Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa Dana-Farber Cancer Institute Recruiting
2
Trial Phase
170
Trial Size
21.99 22 miles
The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma Georgetown University Recruiting
2
Trial Phase
15
Trial Size
21.99 22 miles
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer Halozyme Therapeutics Recruiting
2
Trial Phase
237
Trial Size
21.99 22 miles
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863 GlaxoSmithKline Recruiting
1
Trial Phase
80
Trial Size
21.99 22 miles
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC Target PharmaSolutions, Inc. Recruiting N/A
5000
Trial Size
21.99 22 miles
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease Incyte Corporation Recruiting
3
Trial Phase
436
Trial Size
21.99 22 miles
Dose Escalation and Expansion of JTX-2011 Alone or in Combination With Anti-PD-1 in Subjects With Advanced Solid Tumors Jounce Therapeutics, Inc. Recruiting
1
Trial Phase
282
Trial Size
21.99 22 miles
Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery Academic and Community Cancer Research United Recruiting
2
Trial Phase
40
Trial Size
21.99 22 miles
Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics Georgetown University Recruiting
2
Trial Phase
300
Trial Size
21.99 22 miles
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease Georgetown University Recruiting
2
Trial Phase
75
Trial Size
21.99 22 miles
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab Georgetown University Recruiting
2
Trial Phase
72
Trial Size
21.99 22 miles
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects University of Florida Recruiting
3
Trial Phase
225
Trial Size
21.99 22 miles
Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab Biogen Recruiting
3
Trial Phase
100
Trial Size
21.99 22 miles
Riociguat in Scleroderma Associated Digital Ulcers University of Michigan Recruiting
2
Trial Phase
20
Trial Size
21.99 22 miles
A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors Hoffmann-La Roche Recruiting
2
Trial Phase
120
Trial Size
21.99 22 miles
M3541 in Combination With Radiotherapy in Subjects With Solid Tumors EMD Serono Recruiting
1
Trial Phase
30
Trial Size
21.99 22 miles
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron Hoosier Cancer Research Network Recruiting
2
Trial Phase
44
Trial Size
21.99 22 miles
Study of Oral Treatments for Hepatitis C University of Florida Recruiting
4
Trial Phase
2670
Trial Size
21.99 22 miles
A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease ACADIA Pharmaceuticals Inc. Recruiting
2
Trial Phase
432
Trial Size
21.99 22 miles
Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli Georgetown University Recruiting N/A
60
Trial Size
21.99 22 miles
Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer Georgetown University Recruiting
2
Trial Phase
58
Trial Size
21.99 22 miles
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH) Target PharmaSolutions, Inc. Recruiting N/A
15000
Trial Size
21.99 22 miles
Surefire Institutional DEB-TACE Georgetown University Recruiting N/A
15
Trial Size
21.99 22 miles
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) Pfizer Recruiting
3
Trial Phase
640
Trial Size
21.99 22 miles
Burst Biologics Foot and Ankle Registry Smart-Surgical Inc. dba Burst Biologics Recruiting N/A
300
Trial Size
21.99 22 miles
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors Genentech, Inc. Recruiting
1
Trial Phase
572
Trial Size
21.99 22 miles
Acupressure for Cancer-Related Fatigue Georgetown University Recruiting N/A
124
Trial Size
21.99 22 miles
A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, Bristol-Myers Squibb Recruiting
3
Trial Phase
340
Trial Size
21.99 22 miles
The Lung Screening, Tobacco and Health Project Georgetown University Recruiting
3
Trial Phase
1330
Trial Size
21.99 22 miles
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Reata Pharmaceuticals, Inc. Recruiting
3
Trial Phase
414
Trial Size
21.99 22 miles
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors Bristol-Myers Squibb Recruiting
1
Trial Phase
260
Trial Size
21.99 22 miles
Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome (SBS) Who Completed TED-C14-006 Shire Recruiting
3
Trial Phase
34
Trial Size
21.99 22 miles
Dasatinib and Osimertinib (AZD9291) in Advanced Non-Small Cell Lung Cancer With EGFR Mutations Georgetown University Recruiting
1
Trial Phase
38
Trial Size
21.99 22 miles
Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor Hoffmann-La Roche Recruiting
1
Trial Phase
45
Trial Size
21.99 22 miles
Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients Georgetown University Recruiting
2
Trial Phase
46
Trial Size
21.99 22 miles
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma Georgetown University Recruiting
1
Trial Phase
41
Trial Size
21.99 22 miles
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) Hoffmann-La Roche Recruiting
3
Trial Phase
600
Trial Size
21.99 22 miles
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
950
Trial Size
21.99 22 miles
Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease Georgetown University Recruiting
2
Trial Phase
42
Trial Size
21.99 22 miles
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS) University of Colorado, Denver Recruiting
4
Trial Phase
300
Trial Size
21.99 22 miles
MEND 2: Making Treatment Decisions Using Genomic Testing Georgetown University Recruiting N/A
135
Trial Size
21.99 22 miles
Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid. Genkyotex SA Recruiting
2
Trial Phase
102
Trial Size
21.99 22 miles
Migraine Treatment With Nerivio Migra Neurostimulation Device Theranica Recruiting N/A
160
Trial Size
21.99 22 miles
Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH) Shire Recruiting
2
Trial Phase
266
Trial Size
21.99 22 miles
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis AbbVie Recruiting
3
Trial Phase
270
Trial Size
21.99 22 miles
LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy Georgetown University Recruiting
1
Trial Phase
44
Trial Size
21.99 22 miles
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma Bristol-Myers Squibb Recruiting
3
Trial Phase
900
Trial Size
21.99 22 miles
Comparing the Clinical Outcomes of DermACELL® With Integra® Bilayer Wound Matrix Georgetown University Recruiting N/A
100
Trial Size
21.99 22 miles
Study to Assess the Efficacy and Safety of Umbralisib in Patients With Non-Follicular Indolent Non-Hodgkin's Lymphoma TG Therapeutics, Inc. Recruiting
2
Trial Phase
40
Trial Size
21.99 22 miles
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150] Hoffmann-La Roche Recruiting
3
Trial Phase
480
Trial Size
21.99 22 miles
Outcomes of Post-operative Diet in Children Following Tonsillectomy and Adenoidectomy Georgetown University Recruiting N/A
86
Trial Size
21.99 22 miles
Effect of Cigarette Pack Warnings and Packaging Among Young Adult Smokers Georgetown University Recruiting N/A
400
Trial Size
21.99 22 miles
Older Breast Cancer Patients: Risk for Cognitive Decline Georgetown University Recruiting N/A
850
Trial Size
21.99 22 miles
Treatments for Anxiety: Meditation and Escitalopram Georgetown University Recruiting
4
Trial Phase
370
Trial Size
21.99 22 miles
Expanded Access Program With Nivolumab to Treat Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
22.16 22 miles
Research Tissue Bank Myeloproliferative Disorders-Research Consortium Recruiting N/A
400
Trial Size
22.16 22 miles

View Legend


Listings display only those clinical trials that have locations in the USA. Distances calculated are an approximation only.

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.